KALA BIO, Inc. Common Stock (KALA) is a publicly traded Healthcare sector company. As of May 21, 2026, KALA trades at $2.65 with a market cap of $50.38M and a P/E ratio of -0.82. KALA moved +4.35% today. Year to date, KALA is -91.40%; over the trailing twelve months it is -98.66%. Its 52-week range spans $2.52 to $1,030.00. Rallies surfaces KALA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for KALA shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $2.65 |
| Market Cap | $50.38M |
| P/E Ratio | -0.82 |
| EPS | $-3.31 |
| Dividend Yield | 0.00% |
| 52-Week High | $1,030.00 |
| 52-Week Low | $2.52 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-26.98M |
| Gross Margin | 0.00% |
KALA analyst coverage data. Average price target: $0.00.